NEW YORK (GenomeWeb) – HTG Molecular Diagnostics today announced it has again received ISO 13485:2003 certification for the design, manufacture, and distribution of instruments, software, reagents, and test kits for gene expression analysis.

The certification covers design, development, manufacture, sale, and distribution of the firm's quantitative nuclease-protection assay (qNPA) gene expression analysis products and services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.